Genome & Beyond: Matrix Partners Co-Hosts Life Science Tools Forum at VB100 Future Healthcare 100 Summit 2023
Over the past decade, the global healthcare industry has undergone significant restructuring, a transformation accelerated by the COVID-19 pandemic since 2020. Having withstood the compounded challenges of global upheavals and the century-defining pandemic from 2020 to 2022, 2023 marked the first year for implementing the strategic deployments outlined at the 20th National Congress of the Communist Party of China, as well as a critical year for advancing the 14th Five-Year Plan. Only by accumulating strength, demonstrating the resilience to “stand firm amidst countless trials,” and embodying the spirit to “press forward despite mounting difficulties,” can innovators in the healthcare sector reinforce their confidence through decisive action, thereby delivering a robust response to the era’s demand for high-quality development in healthcare.
The 7th Future Healthcare Top 100 Conference, themed “No Boundaries Between East and West,” was co-hosted by VCBeat VB100 and Eggshell Research Institute, in strategic partnership with Shanghai Zhangjiang Group. Integrating cutting-edge academic research insights, comprehensive industry perspectives, and keen awareness of capital trends, the conference took place from May 5–7, 2023, at the Zhangjiang Science Hall in Shanghai. Together with peers, it explored the innovative future of the broader health industry, embarking on a new journey in healthcare innovation.
After six editions, the conference has become China’s largest and most information-rich ecosystem summit for industry–capital integration in the medical and health innovation sector. Centered on “connecting global wisdom, sharing cutting-edge technologies, inspiring the technological future, and focusing on venture capital interaction,” it sets the direction for innovation and investment in China’s healthcare field. The 7th Future Healthcare Top 100 Conference in 2023 will feature three flagship summits, more than 20 thematic forums across specialized sectors, release the Future Healthcare Top 100 series rankings and awards, publish over ten series reports, and host seven concurrent networking events. It will bring together a diverse roster of guests and attendees—including government agencies, academicians and scientists, research and clinical experts, Fortune 500/listed companies, top-tier investment institutions and securities firms, and innovative healthcare enterprises—creating a gathering of ideas that offers insights to the industry and ushers in a new future.
“Only ask for courage, only ask for blossoming, ask not of west or east” makes a powerful arrival!
Strategic Partnership with Matrix Partners China: Exploring the Mysteries and Opportunities in Life Science Tools
In the turbulent year of 2022, Matrix Partners China maintained a relatively active investment pace, continuing to focus on China, empowering technological and industrial innovation, and creating value beyond commerce for society. Healthcare has been a sector of long-term focus for Matrix Partners China since its inception. Over the past few years, the firm’s healthcare team has continuously refined its investment strategies and deepened its understanding of specific sub-sectors.
Since the first half of 2020, Matrix Partners China has identified systemic investment opportunities in life science tools. To date, it has achieved comprehensive coverage across all sub-sectors of the upstream life sciences industry chain. As one of the earliest investors to establish a presence in this field, Matrix Partners China has seen several of its portfolio companies evolve into sector leaders. Together with its portfolio companies, industry experts, and other stakeholders, Matrix Partners China has cultivated a unique “Matrix Life Science Tools Ecosystem.” This ecosystem fosters multi-dimensional interactions and win-win collaborations in areas such as business synergy, talent acquisition, and external partnerships.
From May 5 to 7, 2023, the 7th Future Healthcare Top 100 Conference will present a comprehensive healthcare industry exchange event that integrates “cutting-edge academic and research insights, holistic industry perspective, and keen capital market trends.”VCBeat VB100CombinationMatrix Partners China, co-hosted byLife Science Tools Forum, comprehensively explore the current development trends of the industry ecosystem from multiple perspectives, deepen academic exchanges and cooperation in the fields of life sciences and health, promote interdisciplinary integration and development, and foster collaboration across upstream and downstream industries.
Matrix Partners China Invites You to the Life Sciences Tools Forum
Conference Time:
May 5–7, 2023
Life Science Tools Forum Time:
May 6, 2023
Conference Venue:
Shanghai Zhangjiang Science Hall (No. 1393 Haike Road, Pudong New Area, Shanghai)
Conference Registration:
(Full Conference Pass: Enjoy Access to 30+ Forums)
About Matrix Partners China
Matrix Partners China, founded in 2008, is a leading venture capital firm in the industry that has long focused on early-stage and early-growth investments. It specializes in investing in new technologies, hard tech, industrial digitalization, healthcare, frontier technologies, and new consumer sectors. To date, it has invested in more than 900 companies, including XPeng Motors, Li Auto, Hithium Energy Storage, Chehaoduo Group, Ele.me, Youzan, Ronbay Technology, XGIMI, Momo, PingCAP, Peijia Medical, Beisen, Zihai Guo, Chuanzhi Education, MetaX, Jian Ai, SemiDrive Technology, Megarobo,芯耀辉 (CoreYH),芯华章 (X-Epic), Enhe Bio, and Jinyi Shengshi.
Conference-related
